US2019029941A1PendingUtilityA1
Retinoid double conjugate compounds, compositions thereof, and methods for treating of skin conditions
Est. expiryNov 15, 2033(~7.3 yrs left)· nominal 20-yr term from priority
Inventors:Joseph A. Lewis, Ii
C07C 2601/16C07C 403/20A61Q 19/08A61K 8/671A61Q 19/00
59
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Provided are methods of treating certain skin conditions in a human in which the skin of the human in need of such treatment is contacted with an effective amount of a particular composition.
Claims
exact text as granted — not AI-modified1 . A method of treating a skin condition in a human, comprising:
contacting the skin of the human in need of such treatment with an effective amount of a composition comprising the molecule of formula (Id),
wherein
R 3 is H or alkyl consisting of 1 carbon atom, and
R 6 is alkyl consisting of 1, 2, 3, or 4 carbon atoms; and
wherein the skin condition is aging, dryness, hyperpigmentation, icthyosis, loss of skin elasticity, loss of skin elasticity resiliency, loss of extra cellular matrix components in the skin, reduced dermal volume, reduced epidermal volume, loss of fibroblast activity, sallow complexion, actinic keratoses, or a combination thereof.
2 . The method of claim 1 , wherein the composition further comprises:
a carrier; and 0.01 to 0.5 wt %, relative to the total weight of the composition, of the molecule of formula Id.
3 . The method of claim 1 , wherein the composition further comprises:
an α-hydroxy acid.
4 . The method of claim 1 , wherein the molecule has the formula (If)
5 . The method of claim 1 , wherein the molecule has the formula (Ig)
6 . The method of claim 1 , wherein the molecule of formula (Id) is present in an amount of 0.01 to 0.25 wt %.
7 . The method of claim 1 , wherein the molecule of formula (Id) is present in an amount of 0.01 to less than 0.2 wt %.
8 . The method of claim 1 , wherein the molecule of formula (Id) is present in the amount of 0.02 to 0.175 wt %.Join the waitlist — get patent alerts
Track US2019029941A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.